Add BrightSurf on Google Email

Cyclin D1 expression in penile cancer

Researchers found cyclin D1 expression in patients with penile cancer (PC) is associated with clinical and histopathological features. Patients with cyclin D1 expression had lower disease-free survival compared to the cyclin D1-negative group.

SourceImpact Journals LLC·JournalOncotarget·TypeObservational study·DateMay 15, 2024

Towards a better understanding of endothelial cell transformation in cancer progression

A novel reporter cell experimental system enables the visualization of sequential changes during endothelial-mesenchymal transition (EndoMT) induced by transforming growth factor-β. Researchers identified CD40 as a potential partial EndoMT marker, which suppresses the transition from partial to full EndoMT.

SourceTokyo Medical and Dental University·JournalCancer Science·TypeExperimental study·DateFeb 7, 2024

OncoDNA announces publication of peer-reviewed study in Oncotarget assessing the utility of its unique biomarker analysis and interpretation platform in clinical decision making

A peer-reviewed study published in Oncotarget found that OncoDNA's comprehensive testing and analysis services, combining multiple biomarkers, increased oncologists' ability to make informed treatment decisions. The study showed a significant improvement in overall survival for late-stage patients, from six months to over 12 months.

SourceImpact Journals LLC·JournalOncotarget·DateApr 17, 2018

New molecular markers for tumor aggressiveness in biliary tract cancer

Researchers identified LNγ2, LNβ3, and active MMP7 as molecular markers for tumor aggressiveness in biliary tract cancer. The study found that these markers were associated with tumor progression, depth of invasion, and advanced stage. Down-regulation of MMP7 expression resulted in a significant decrease in cancer cell invasion.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateAug 26, 2009